News | Brachytherapy Systems, Women's Healthcare | September 08, 2020

Florida Cancer Center Upgrades to AccuBoost Digital

Sandra Sha, M.D., a distinguished physician as recognized by the Florida Medical Association, specializing in breast cancer treatment

Sandra Sha, M.D.

September 8, 2020  Advanced Radiation Therapy has completed the installation of the AccuBoost Digital platform at the Central Florida Cancer Institute (CFCI). This innovation in breast brachytherapy leverages the superior resolution of digital mammography for the delivery of breast radiation therapy. Along with improvements to treatment workflow, AccuBoost Digital delivers images in real-time with unparalleled clarity. This provides clinical treatment teams with excellent imaging for precise target localization, maximizing the sparing of healthy tissues and organs from undesired radiation. The clinical team at CFCI has over a decade of experience in offering the AccuBoost treatment on the first-generation platform and has seen excellent clinical results. CFCI has acquired the new AccuBoost Digital breast brachytherapy solution with the goal of improving the treatment workflow, reducing treatment time, improving the patient experience, and to benefit from the updated user interface.

Sandra Sha, M.D., a distinguished physician as recognized by the Florida Medical Association, specializing in breast cancer treatment, commented, “Our purchase of the AccuBoost Digital solution is the latest technology update we have added to bring the most advanced breast cancer treatment technologies to the women of Central Florida. Having seen excellent clinical results in our use of the AccuBoost technique for over a decade, we wanted to add the capabilities and benefits this new release offers to our patients.”

Lead therapist and long time AccuBoost user, Michele Jolly, added, “After only a couple days of use, the advantages of the new low profile design have already been realized. Patient setup, particularly for heavier patients, is much easier, and the revised patient flow is very efficient.”

For more information: www.accuboost.com

Related Content

Radiologists have recently taken on the role of activists and are tackling pressing issues in healthcare, including breast density

Getty Images

Feature | Women's Health | January 20, 2021 | By Fazila Seker, Ph.D.
Radiologists — who have long been professionals in the metaphorical and literal back-rooms of healthcare — have recen
A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant the

A, Contrast-enhanced axial T1-weighted fat-saturated image from baseline MRI before initiation of neoadjuvant therapy shows irregular mass (arrow) in upper inner right breast corresponding to biopsy-proven carcinoma. B, Contrast-enhanced axial T1-weighted fat-saturated image from follow-up MRI performed 3 months after initiation of neoadjuvant therapy shows decrease in size of right breast cancer (arrow). C, Contrast-enhanced axial T1-weighted fat-saturated image 3 months after initiation of neoadjuvant therapy shows new mass (arrow) in upper outer left breast that was assessed as BI-RADS 4. Pathologic examination from MRI-guided core biopsy of new suspicious mass revealed benign usual ductal hyperplasia. No atypia or malignancy was identified. Image courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | MRI Breast | January 15, 2021
January 15, 2021 — According to ARRS' ...
A targeted intervention providing mammograms to hospitalized Medicaid patients can help patients complete overdue breast cancer screening

Getty Images

News | Mammography | January 14, 2021
January 14, 2021 — Completing cancer screening tests, such as...
DB-I website features new educational tools and streamlined user experience to improve access to medically sourced breast density content
News | Breast Density | January 13, 2021
January 13, 2021 — DenseBreast-info.org (DB-I) invites he
This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately
News | Mammography | January 12, 2021
January 12, 2021 — Therapixel announced that...
World-first techniques for predicting breast cancer risk from mammograms that were developed in Melbourne could revolutionise breast screening by allowing it to be tailored to women at minimal extra cost

Getty Images

News | Mammography | January 06, 2021
January 6, 2021 — World-first techniques for predicting breast cancer risk from...
Transaction accelerates Hologic’s entry into oncology growth market, provides new lab capabilities

Getty Images

News | Breast Imaging | January 06, 2021
January 6, 2021 — Hologic, Inc., a global leader in women's...
Smart Breast Corporation (SmartBreast), a privately held company focused on breast cancer screening and detection, announced today that it has acquired certain molecular breast imaging (MBI) assets from Dilon Technologies, Inc. (Dilon) for an undisclosed amount.
News | Breast Imaging | January 04, 2021
January 4, 2021 — Smart Breast Corporation (SmartBreast), a privately held company focused on...